Proposed decision calendar—not statutory deadlines except where identified above:
| Period | Owner or investment-committee deliverable |
|---|---|
| October 20–31 | Reconciled trailing accounts, event-normalized trading and updated lender terms |
| November | Common-case operator comparison, affiliation analysis and independently reviewed capital budget |
| Before December 1, where applicable | Counsel-led resolution of NYC staffing-transition exposure |
| Before year-end approval | Monthly downside liquidity, evidence gaps and explicit proceed, renegotiate or defer conditions |
For outsourced research or AI-assisted diligence, require a source date for every material input, a distinction between actuals and forecasts, permission to use benchmark data and reproducible calculations. Keep confidential guest information out of research submissions.
Our proposed stop condition: Do not treat an unresolved material assumption as zero cost. Record the exposure, assign an owner and identify the evidence needed to clear it.
Reply “2027” with your market, room count and upcoming decision to scope a Quiet-Month Liquidity Planner, Soft-Brand Break-Even analysis or acquisition underwriting review.
This outlook is research, not a promise of returns, an appraisal, a legal opinion or a lending commitment.